IL16 and prostate carcinoma: Meanwhile, a study evaluated the relationship between pre-diagnostic IL-16 serum levels and prostate cancer risk in 932 Caucasian cases and 942 controls in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (12).